Xiamen Kingdomway Group Co (002626.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE1000018X4

Price
17.55 CNY
Market cap
10.70 bn CNY
P/E (2025)
31.49
P/S (2025)
3.18
Dividend yield
2.28 %
Net margin
10.10 %
Return on equity (ROE)
7.62 %
Return on assets (ROA)
4.41 %

Xiamen Kingdomway Group Co financials

Fiscal year20242025
Revenue3.24 bn CNY3.37 bn CNY
Gross profit1.24 bn CNY1.32 bn CNY
Operating income482.30 m CNY532.57 m CNY
EBIT501.00 m CNY437.80 m CNY
Net income341.99 m CNY339.91 m CNY
Diluted EPS – continuing operations0.56 CNY0.56 CNY

Full history since 2008, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Xiamen Kingdomway Group Co

Xiamen Kingdomway Group Company engages in the manufacturing and sale of the nutrition and health products in China and internationally. The company also offers dietary supplements, functional foods, and sports nutrition. It offers its products under the Doctor's Best, Zipfizz, Kingdaway, Labrada, Prosupps, Wu Kun, Viactiv, RxSugar, LeanBody, and Jinlexin brands. It sells its products through online platforms and supermarkets. The company was formerly known as Xiamen Jindawei Vitamin Co., Ltd. Xiamen Kingdomway Group Company was founded in 1997 and is based in Xiamen, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.